The International Paralympic Committee (IPC) has announced that Azerbaijani powerlifter Maharram Aliyev has been suspended for four years for an Anti-Doping Rule violation and consequently will no longer be competing at the upcoming Rio 2016 Paralympic Games.
Aliyev returned an adverse analytical finding for two substances - methandienone metabolite and dehydrochloromethyltestosterone metabolite (DHCMT) - in a urine sample provided on 19 February 2016 after he had competed in the men’s over 107kg category at the 7th FAZZA Powerlifting Championships in Dubai, UAE.
These substances are included on the World Anti-Doping Agency (WADA) 2016 Prohibited List under the category S1.1a Exogenous Anabolic Androgenic Steroids (AAS) and are prohibited at all times, both in and out of competition.
As a result of his violation, Aliyev will be ineligible from competition for four years from 21 March 2016, the date the athlete was notified and provisionally suspended, until 20 March 2020.
All Aliyev’s results obtained from the date of the test and onwards will be disqualified including forfeiture of any medals, points, records and prizes.
The principle of strict liability applies to anti-doping matters. Therefore, each athlete is strictly liable for the substances found in his or her sample, and that an anti-doping rule violation occurs whenever a prohibited substance (or its metabolites or markers) is found in his or her bodily specimen, whether or not the athlete intentionally or unintentionally used a prohibited substance or was negligent or otherwise at fault.
As a signatory of the World Anti-Doping Code (WADC), the IPC remains committed to a doping free sporting environment at all levels. The IPC, together with the International Federations and the National Paralympic Committees, established the IPC Anti-Doping Code to prevent doping in sport for Paralympic athletes, in the spirit of fair play. The IPC Anti-Doping Code is in conformity with the general principles of the WADC.